The DOI matches its Crossref record.
A Phase Ib, Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy
Abstract
BACKGROUND: We performed the first multiple dose study of remimazolam designed to assess both the feasibility of maintaining suitable sedation during colonoscopy and reversing the sedative effects of remimazolam with flumazenil. METHODS: Healthy volunteers received fentanyl followed by remimazolam for sedation during colonoscopy. Three dose groups of 15 volunteers each received remimazolam in increasing initial doses, plus top-up doses to maintain sedation for a 30-minute period. In a separate double-blind crossover part of the trial, 6 volunteers were sedated with a single high dose of remimazolam, followed by flumazenil or placebo to reverse the sedation. RESULTS: Successful sedation that was adequate for colonoscopy was achieved in >70% of subjects. After the procedure, subjects rapidly recovered to fully alert, with a median of <10 minutes overall. Failures were due to the inability to sedate or adverse events, with 1 subject failing due to hypotension (arterial blood pressure 80/40) and low SpO2 (<90%). There were no serious adverse events reported, and no events that were unexpected with the combination of a benzodiazepine and fentanyl. The study also showed that sedation was rapidly reversible (1.0 minutes flumazenil vs 10.5 minutes placebo) without resedation. CONCLUSIONS: Remimazolam has the attributes of a sedative drug, with success rates comparable with recent studies of other drugs. Remimazolam provided adequate sedation in 33 of 44 subjects undergoing colonoscopy, and its sedative effects were easily reversed with flumazenil.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Doi, M., Morita, K., Takeda, J., Sakamoto, A., Yamakage, M., & Suzuki, T. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02788-6 · Cited by 484
Schüttler, J., Eisenried, A., Lerch, M., Fechner, J., Jeleazcov, C., & Ihmsen, H. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003103 · Cited by 338
Chen, S., Yuan, T., Zhang, J., Bai, H., Tian, M., Pan, C., Bao, H., Jin, X., Ji, F., Zhong, T., et al. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15188 · Cited by 270
Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent
Kilpatrick, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690875 · Cited by 262
Remimazolam: pharmacological characteristics and clinical applications in anesthesiology
Kim, K. M. (2022) · Anesthesia and Pain Medicine · doi:10.17085/apm.21115 · Cited by 257
Keam, S. J. (2020) · Drugs · doi:10.1007/s40265-020-01299-8 · Cited by 188
Guo, J., Qian, Y., Zhang, X., Han, S., Shi, Q., & Xu, J. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01713-6 · Cited by 153
Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!
Masui, K. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02755-1 · Cited by 123
Efficacy and safety of remimazolam in endoscopic sedation-A systematic review and meta-analysis
Zhu, X., Wang, H., Yuan, S., Li, Y., Jia, Y., Zhang, Z., Yan, F., & Wang, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655042 · Cited by 75
“In addition, we excluded one trial at the fulltext review stage; it was a dose-finding study of remimazolam involving volunteers undergoing colonoscopy, and it assessed the antagonistic effect of flumazenil in reversing remimazolam sedation (19).”
BackgroundLu, K., Wei, S., Ling, W., Wei, Y., Ran, X., Huang, H., Wang, M., Wei, N., Liao, Y., Qin, Z., et al. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13797 · Cited by 71
Shi, W., Cheng, Y., He, H., Fang, Q., Hu, Y., Xu, X., Shuai, Y., Zhang, J., Fang, X., Wang, Z., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.09.014 · Cited by 57
Hasegawa, G., Hirata, N., Yoshikawa, Y., & Yamakage, M. (2022) · Journal of Anesthesia · doi:10.1007/s00540-022-03037-8 · Cited by 56
Xin, Y., Chu, T., Wang, J., & Xu, A. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01805-3 · Cited by 45
Zhu, T. (2023) · Pain Physician Journal · doi:10.36076/ppj.2023.26.e761 · Cited by 42
Wei, A., Ma, S., Dou, Y., Wang, X., Wu, J., Zhou, S., Deng, Y., Liu, X., Li, D., & Yang, M. (2023) · PLOS ONE · doi:10.1371/journal.pone.0282930 · Cited by 33
Induction and maintenance of procedural sedation in adults: focus on remimazolam injection
Chen, W., Chen, S., & Huang, Y. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1901575 · Cited by 25
Metadata
- Authors
- Worthington, M. T., Antonik, L. J., Goldwater, D. R., Lees, J. P., Wilhelm-Ogunbiyi, K., Borkett, K. M., & Mitchell, M. C.
- Venue
- Anesthesia & Analgesia
- Published
- 2013-11
- Volume
- 117
- Issue
- 5
- Pages
- 1093-1100
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2104814996
- Cited by
- 184
- References
- 0
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.